5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Eris Lifesciences Ltd.

•
eris.co.inBSE: 540596NSE: ERIS
Market Cap₹ 18,506 Cr.
Current Price
High / Low₹ 1,745 / 1,200
Stock P/E28.7
Book Value₹ 291
Price to Book4.62
Dividend Yield0.00 %
ROCE14.5 %
ROE19.2 %
Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has consistently been profitable over the last 5 years
  • Company has delivered good sales growth of 20.9% CAGR over last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.47x)
  • Operating margins have improved to 34.1% from 31.0%
  • Working capital cycle has improved - days down from -19 to -60
  • Company generates healthy free cash flow

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Though reporting repeated profits, the company pays out little dividend (0.0%)
  • Inventory has been piling up - inventory days up from 32 to 43

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY TOTAL MKTNIFTY 500NIFTY SMLCAP 250
S.No.Name
1.SUNPHARMA1868.5037.06448315.740.862901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9482.7586.06251737.220.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4931.9086.01187593.620.77566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1129.0024.95112618.180.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1368.0032.79110515.040.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1933.2595.54104455.860.10362.07123.942026.3129.1018.2031.50
7.AUROPHARMA1690.0026.1997238.860.241032.0325.229150.3517.4412.7620.54
8.LUPIN2092.0017.3095660.020.861416.9816.018276.8934.2828.8629.59
9.DRREDDY1143.2029.6195420.610.70435.60-69.108099.80-5.2113.7510.63
10.MANKIND2266.0045.8293596.020.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2439.5538.2968850.120.10482.83927.884018.4831.3520.3520.03
12.ERIS1335.3528.7418505.720.00143.3214.56873.2513.1814.4733.88
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
460501483547716739722703772790801752873
297324311403470477477453496504526483696
Operating Profit163176173145246262245250275286275269178
OPM %35.47%35.24%35.72%26.45%34.36%35.49%33.93%35.54%35.68%36.19%34.34%35.80%20.33%
13415254833-1722
Interest17161833605957544950494647
Depreciation41424654768081777169707072
Profit before Tax11212611677116129116129160172145161179
Tax %16.75%3.11%12.44%-3.86%22.48%25.39%25.18%20.59%22.47%22.16%25.15%-74.52%20.15%
Net Profit0000899687102125134109279143
6.979.087.555.226.116.736.156.908.668.827.3220.6010.28

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
7498569821,0741,2121,3471,6852,0092,8943,1293,217
4805336377067818621,1481,3341,8762,0202,209
Operating Profit2693223453684314855376751,0171,1091,008
OPM %35.91%37.65%35.13%34.25%35.54%36.01%31.85%33.59%35.15%35.45%31.33%
252632169261124181-10
Interest111232242685231193191
Depreciation232636504365117183315280281
Profit before Tax270312317331394442405431489639658
Tax %8.79%5.53%8.26%10.52%9.98%8.23%7.53%7.93%23.36%-1.40%-1.34%
Net Profit247295291297355406374397375648667
EPS17.9521.3921.1321.5926.1429.8828.0728.8325.8344.73—
Dividend Payout %0.00%0.00%0.00%13.14%21.03%20.12%26.15%0.00%28.45%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
18%
5 Years:
21%
3 Years:
23%

COMPOUNDED PROFIT GROWTH

10 Years:
17%
5 Years:
12%
3 Years:
17%

STOCK PRICE CAGR

10 Years:
—
5 Years:
12%
3 Years:
18%
1 Year:
-21%

RETURN ON EQUITY

10 Years:
27%
5 Years:
18%
3 Years:
17%
Last Year:
19%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

May 29

₹ 7.21

Rs.7.2100 per share(721%)Interim Dividend

2025

Feb 13

₹ 7.35

Interim Dividend

2022

Aug 11

₹ 7.35

Interim Dividend

2021

Aug 5

₹ 6.01

Interim Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital14141414141414141414
Minority Interest24251800-025636417-7
5538481,1361,2801,5591,8932,1802,5682,8313,875
113811841620957722,4482,1931,455
Trade Payables399184100103118125219332330
917144288-73579261,0781,581
Total Liabilities7321,4281,4811,4371,7032,1133,4726,8106,8667,247
2327717618758549182,5684,3195,3065,188
Capital Work in Progress0010024211967171
3033653567829452037166762
5665836994118131189335437
0000000422459680
Cash & Bank2118673852581,40122367
139215273347422480656445409642
Total Assets7321,4281,4811,4371,7032,1133,4726,8106,8667,247

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
2533042953234444623694861,065538
Cash from Investing-184-590-5123-323-320-982-1,855-80-369
Cash from Financing-24363-221-335-82-456881,380-881-314
-88-360-3014-211104-145

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
54.8854.8754.8654.8554.8354.8554.8553.9254.14
14.598.008.368.438.397.216.856.395.76
16.2318.6418.0718.0718.1819.3620.3120.3520.71
Government0.000.000.000.000.000.000.000.000.00
14.3018.4718.7218.6618.5918.5717.9919.3319.40

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-10
Rumour Verification - Regulation 30(11)

2026-09-10 - Eris Lifesciences Limited has informed the Exchange about Rumour Verification - Regulation 30(11)

2026-09-09
Agreements

2026-09-09 - Eris Lifesciences Limited has informed the Exchange about Loan Agreement

2026-09-07
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-07 - Eris Lifesciences Limited has informed the Exchange about Schedule of meet

2026-09-03
Copy of Newspaper Publication

2026-09-03 - Eris Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-02
Copy of Newspaper Publication

2026-09-02 - Eris Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-02
Shareholders meeting

2026-09-02 - Eris Lifesciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026

2026-08-31
Outcome of Board Meeting

2026-08-31 - Eris Lifesciences Limited has informed the Exchange regarding Outcome of Board Meeting held on August 31, 2026.

2026-08-24
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-24 - Eris Lifesciences Limited has informed the Exchange about Schedule of meet

2026-08-12
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-12 - Eris Lifesciences Limited has informed the Exchange about Schedule of meet

News

Recent coverage and analyst commentary for ERIS

Loading news…

🤖

AI Stock Analyst

Eris Lifesciences Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login